knowledge translation (and exchange) for vaccine-preventable diseases (vpds) cpha conference may 27...
TRANSCRIPT
Knowledge Translation (and Exchange) for Vaccine-Preventable Diseases (VPDs)
CPHA Conference
May 27th, 2014
Lisa Paddle, Nurse Advisor
Presentation Outline
What is Knowledge Translation and Exchange (KTE) and why is it important?
KTE in context of Vaccine-Preventable Disease Surveillance The ‘right’ audience The ‘right’ time The ‘right’ tools Additional Learning Resources/KTE Mechanisms
KTE on Vaccine-Preventable Diseases
2
KTE on Vaccine-Preventable Diseases
3
What is knowledge translation (KT) / exchange (KTE)?
“a dynamic and iterative process that includes synthesis, dissemination, exchange and ethically-sound application of knowledge to improve the health of Canadians, provide more effective health services and products and strengthen the health care system” (Source: Canadian Institutes of Health Research)
This process takes place within a complex system of interactions between researchers and knowledge users that vary in intensity, complexity and level of engagement depending on the nature of the research and the findings as well as the needs of the particular knowledge user
Knowledge Translation Models
KTE on Vaccine-Preventable Diseases
4
Based on 31 planned action theories
Designed to be used by broad range of audiences
Key is importance of appropriate relationships
Fluid, non-linear
KTE on Vaccine-Preventable Diseases
5
Knowledge translation is about the application and use of the best available science to benefit health and well-being.
Knowledge output
Knowledge uptake/ impact
The right information to the right people in the
right way at the right time
VPD Surveillance: How to translate science to knowledge
KTE on Vaccine-Preventable Diseases
6
KTE on Vaccine-Preventable Diseases
7
Who were our key surveillance stakeholders?
Immunization and Respiratory Infectious Diseases
Professional organizations:•Canadian Paediatric Society (CPS)•Immunize Canada•Society for Obstetricians & Gynaecologists (SOGC)•Canadian Public Health Association (CPHA)•Etc.
Government:•PHAC (other Centres & Divisions)•National Microbiology Laboratory (NML)•Health Canada (First Nations, Vaccine Regulation)•Provincial / Territorial (P/T) VPD / immunization programs
F-P-T / Expert Committees:•Canadian Immunization Committee (CIC)•National Advisory Committee on Immunization (NACI)•Committee to Advise on Tropical Medicine and Travel (CATMAT)
International organizations:•Centres for Disease Control & Prevention (CDC)•Pan-American Health Organization (PAHO)•World Health Organization (WHO)
Immunization providers:•Local public health units•Primary health providers •Hospitals•Long-Term Care Homes•Occupational health services
Research community:•Canadian Association of Immunization research and Evaluation (CAIRE)•PHAC-CIHR Influenza Research Network (PCIRN)•Vaccine evaluation centres•IMPACT•Individual researchers & students
General public:•Individuals / parents•Media •Public advocacy groups
What was our key mechanism?
KTE on Vaccine-Preventable Diseases
8
KTE on Vaccine-Preventable Diseases
9
Objectives of Vaccine-Preventable Disease Surveillance
To provide timely, quality national surveillance data to detect trends in disease incidence
To provide information to support program planning and evaluation, outbreak response and future policy and program decision-making
To increase knowledge and understanding of the epidemiology of vaccine preventable diseases through innovative enhanced surveillance systems and research
Goal of Knowledge Translation in the Context of VPD Surveillance
To align national VPD surveillance products with the information needs of key partners & stakeholders and effectively (and efficiently) inform immunization and vaccine-preventable disease program decisions.
VPD’s include:Invasive meningococcal disease (IMD) Varicella
Invasive pneumococcal disease (IPD) Polio
Pertussis Diphtheria
Measles Tetanus
Mumps Haemophilus influenza disease
Rubella GBS/iGAS*
KTE on Vaccine-Preventable Diseases
10
KTE Strategy for Vaccine-Preventable Disease Surveillance
Notifiable Diseases On-line for aggregate case counts at the national level Routine cycle for publication of surveillance reports up to 2023 (Canada
Communicable Disease Reports) Q1 (Polio/AFP; measles; rubella; CRS) Q2 years (IMD) Q 5 years (Invasive Bacterial Diseases including Hi, IPD, iGBS, iGAS,
International Circumpolar Surveillance, Pertussis) Exploring options around weekly online measles reports
VPD surveillance on Agency Website All products (e.g. Canadian Immunization Guide) will “point” here.
National Advisory Committee on Immunization (NACI) Statements For product or strain-specific epidemiologic analysis
Peer Review journals for specific level of analysis Disease Guidelines for epidemiologic summaries
11
KTE on Vaccine-Preventable Diseases
Government of Canada Web Renewal Action Plan (GCWRAP)
Out with the Old, in with the New
12
www.Canada.ca by the end of 2016
One website User-centric Modernized, leaner Accessible (hand-held
devices as well as assistive technologies)
Resources +
“This single site (Canada.ca) approach will require that the Government of Canada fundamentally transform its web presence to better meet the needs of Canadians by being user-centric.”
Immunization and Vaccines Landing Page (before)
Website Renewal: Out with the Old, in with the New
13
KTE on Vaccine-Preventable Diseases
14
Immunization and Vaccines Landing Page (After)
http://www.phac-aspc.gc.ca/im/index-eng.php
General Public (plain language) AND Health Professional audiences
De-duplication Audience-specific Organized and easy to navigate Hyperlinks to relevant content Images/sounds, as appropriate Surveillance section : How is surveillance
done on this VPD in Canada? Health Professionals: information and
resources specific to Health Professionals
15
KTE on Vaccine-Preventable Diseases
New Vaccine-Preventable Diseases Landing Pages
Select KTE Learning Resources
PHAC Knowledge Translation Primer (http://publications.gc.ca/collections/collection_2013/aspc-phac/HP35-37-2012-eng.pdf)
National Collaborating Centre for Methods and Tools (http://www.nccmt.ca/) CIHR: Population and Public Health Institute
(http://www.cihr-irsc.gc.ca/e/27155.html) KT Clearinghouse: www.ktclearinghouse.ca
Institute for Knowledge Mobilization (www.knowledgemobilization,net) Health Evidence (www.health-evidence.org)
16
KTE on Vaccine-Preventable Diseases
Some KTE mechanisms for Vaccine-Preventable diseases
Public Health Agency of Canada Website: Immunization and VaccinesCanadian Immunization GuideCanada Communicable Disease Reports (CCDR)CNPHI (Canadian Network for Public Health Intelligence) (Public Health Alerts)
Acknowledgements
Heather Deehan, Chief Vaccine Preventable Diseases (PHAC) Anita Li, Tiffany Smith, Amanda Shane, Lindsey Sherrard,
Epidemiologists VPD section (PHAC) Dr. Shalini Desai, Medical Specialist (PHAC) Nadine Abboud, Project Management Support (PHAC) Monique St-Laurent, A/Director Vaccine and Immunization Program
Surveillance Division (PHAC) Dr. John Spika, Director General, Centre for Immunization and
Respiratory Infectious Diseases (CIRID) (PHAC) Robert Lerch, Oliver Baclic, Althea House, CIG secretariat (PHAC) Tara Harris, Public Health Ontario(formerly PHAC)
KTE on Vaccine-Preventable Diseases
17